Print

IAVI 003

An open label phase I study to evaluate safety and immunogenicity of a candidate HIV-1 MVA vaccine in healthy, HIV-uninfected volunteers

Trial Details:

I Completed
Medical Research Council (MRC)/Oxford March 14, 2001
MVA.HIVA Gag A
MVA.HIVA Viral Vector - Pox
United Kingdom 8
http://www.oxavi.org